The immunodominant antigen of an ultraviolet-induced regressor tumor is generated by a somatic point mutation in the DEAD box helicase p68

Journal of Experimental Medicine

Volumn 185, Issue 4, 1997, Pages 695-705

  Dubey, Purnima ^a   Hendrickson, Ronald C ^b,e   Meredith, Stephen C ^a   Siegel, Christopher T ^a,d   Shabanowitz, Jeffrey ^b   Skipper, Jonathan C A ^c   Engelhard, Victor H ^c   Hunt, Donald F ^b,c   Schreiber, Hans ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMIUM 51; RNA HELICASE; SYNTHETIC PEPTIDE; TUMOR ANTIGEN;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL MODEL; ANTIGEN RECOGNITION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; FEMALE; FIBROBLAST; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MOUSE; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; SOMATIC MUTATION; T LYMPHOCYTE SUBPOPULATION; TUMOR IMMUNOLOGY;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS; BASE SEQUENCE; CD8-POSITIVE T-LYMPHOCYTES; DEAD-BOX RNA HELICASES; DNA, COMPLEMENTARY; FEMALE; H-2 ANTIGENS; IMMUNODOMINANT EPITOPES; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; NEOPLASMS, EXPERIMENTAL; POINT MUTATION; PROTEIN KINASES; RNA HELICASES; RNA NUCLEOTIDYLTRANSFERASES;

EID: 0031030349     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.185.4.695     Document Type: Article

References (53)

1. Prehn, R.T., and J.M. Main. 1957. Immunity to methylcholanthrene-induced sarcomas. J. Natl. Cancer Inst. 18:769-778.
2. Klein, G., H.O. Sjögren, E. Klein, and K.E. Hellström. 1960. Demonstration of resistance against methylcholanthrene-induced sarcomas of the primary autochthonous host. Cancer Res. 20:1561-1572.
3. Basombrio, M.A. 1970. Search for common antigenicities among twenty-five sarcomas induced by methylcholanthrene. Cancer Res. 30:2458-2462.
4. van den Eynde, B., B. Lethe, A. van Pel, E. De Plaen, and T. Boon. 1991. The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice. J. Exp. Med. 178:489-495.
5. van der Bruggen, P., C. Traversari, P. Chomez, C. Lurquin, E. de Plaen, B. van den Eynde, A. Knuth, and T. Boon. 1991. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science (Wash. DC). 254: 1643-1647.
6. Gaugler, B., B. van den Eynde, P. van der Bruggen, P. Romero, J.J. Gaforio, E. de Plaen, B. Lethe, F. Brasseru, and T. Boon. 1994. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J. Exp. Med. 179:921-930.
7. Boël, P., C. Wildmann, M.-L. Sensi, R. Brasseur, J.-C. Renauld, P. Coulie. T. Boon, and P. van der Bruggen. 1995. BAGE, a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity. 2:167-175.
8. van den Eynde, B., O. Peeters, O. de Backer, G. Gaugler, S. Lucas, and T. Boon. 1995. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J. Exp. Med. 182:689-698.
9. Huang, A.Y.C., P.H. Gulden, A.S. Woods, M.C. Thomas, C.D. Tong, W. Wang, V.H. Engelhard, G. Pasternack, R. Cotter, D. Hunt et al. 1996. The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product. Proc. Natl. Acad. Sci. USA. 93:9730-9735.
10. Coggin, J.H., 1989. Shared crossprotective OFAs on chemically induced rodent sarcomas. Immunol. Today. 10:76-77.
11. Srivastava, P.K., and L.J. Old. Reply to Coggins letter. 1989. Immunol. Today. 10:77.
12. Schreiber, H. 1993. Tumor immunology. In Fundamental Immunology. 3rd edition. W. Paul, editor. Raven Press, Ltd., New York. 1143-1178.
13. Ramarathinam, L., S. Sarma, M. Maric, M. Zhao, G. Yang, L. Chen, and Y. Liu. 1995. Multiple lineages of tumors express a common tumor antigen, P1A, but they are not cross-protected. J. Immunol. 155:5323-5329.
14. Jung, S., and H.-J. Schluesener. 1991. Human T lymphocytes recognize a peptide of single point-mutated, oncogenic ras proteins. J. Exp. Med. 173:273-276.
15. Peace, D.J., W. Chen, H. Nelson, and M.A. Cheever. 1991. T cell recognition of transforming proteins encoded by mutated ras proto-oncogenes. J. Immunol. 146:2059-2065.
16. Skipper, J., and H.-J. Stauss. 1993. Identification of two cytotoxic T lymphocyte-recognized epitopes in the ras protein. J. Exp. Med. 177:1493-1498.
17. Fenton, R.G., D.D. Taub, L.W. Kwak, M.R. Smith, and D.L. Longo. 1993. Cytotoxic T-cell response and in vivo protection against tumor cells harboring activated ras proto-oncogenes. J. Natl. Cancer Inst. 85:1294-1302.
18. + T cells. Proc. Natl. Acad. Sci. USA. 91:3171-3175.
19. Carbone, G., M.G. Borrello, A. Molla, M.G. Rizzetti, M.A. Pierotti, G. Delia Porta, and G. Parmiani. 1991. Activation of ras oncogenes and expression of tumor-specific transplantation antigens in methylcholanthrene-induced murine fibrosarcomas. Int. J. Cancer. 47:619-625.
20. Monach, P.A., S.C. Meredith, C.T. Siegel, and H. Schreiber. 1995. A unique tumor antigen produced by a single amino acid substitution. Immunity. 2:45-59.
21. + T cell-dependent surveillance. Cancer Res. 50:3851-3858.
22. Coulie, P.G., F. Lehmann, B. Lethé, J. Herman, C. Lurquin, M. Andrawiss, and T. Boon. 1995. A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma. Proc. Natl. Acad. Sci. USA. 92:7976-7980.
23. INK4A-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science (Wash. DC). 269:1281-1284.
24. Robbins, P.F., M. El-Gamil, Y.F. Li, Y. Kawakami, D. Loftus, E. Appella, and S.A. Rosenberg. 1996. A mutated β-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes. J. Exp. Med. 183:1185-1192.
25. Brändle, D., F. Brasseur, P. Weynants, T. Boon, and B. van den Eynde. 1996. A mutated HLA-A2 molecule recognized by autologous cytotoxic T lymphocytes on a human renal cell carcinoma. J. Exp. Med. 183:2501-2508.
26. - mutation. Proc. Natl. Acad. Sci. USA. 85:2274-2278.
27. d by cytolytic T cells. Cell. 58:293-303.
28. Mandelboim, O., G. Berke, M. Fridkin, M. Feldman, M. Eisenstein, and L. Eisenbach. 1994. CTL induction by a tumor-associated antigen octapeptide derived from a murine lung carcinoma. Nature (Lond.). 369:67-71.
29. Uenaka, A., T. Ono, T. Akisawa, H. Wada, T. Yasuda, and E. Nakayama. 1994. Identification of a unique antigen peptide pRL1 on BALB/c RL♂ 1 leukemia recognized by cytotoxic T lymphocytes and its relation to the Akt oncogene. J. Exp. Med. 180:1599-1607.
30. de Bergeyck, V., E. de Plaen, P. Chomez, T. Boon, and A. van Pel. 1994. An intracisternal A-particle sequence codes for an antigen recognized by syngeneic cytolytic T lymphocytes on a mouse spontaneous leukemia. Eur. J. Immunol. 24:2203-2212.
31. Ward, P.L., H. Koeppen, T. Hurteau, and H. Schreiber. 1989. Tumor antigens defined by cloned immunological probes are highly polymorphic and are not detected on autologous normal cells. J. Exp. Med. 170:217-232.
32. Townsend, A., C. Öhlen, J. Bastin, H.-G. Ljunggren, L. Foster, and K. Kärre. 1989. Association of class I major histocompatibility heavy and light chains induced by viral peptides. Nature (Lond.). 340:443-448.
33. Cox, A.L., J. Skipper, Y. Chen, R.A. Henderson, T.L. Darrow, J. Shabanowitz, V.H. Engelhard, D.F. Hunt, and C.L. Slingluff, Jr. 1994. Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science (Wash. DC.). 264:716-719.
34. Hunt, D.F., R.A. Henderson, J. Shabanowitz, K. Sakaguchi, H. Michel, N. Sevilir, A.L. Cox, E. Appella, and V.H. Engelhard. 1992. Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. Science (Wash. DC.). 255:1261-1263.
35. Hunt, D.F., J.R. Yates, III, J. Shabanowitz, S. Winston, and C.R. Hauer. 1986. Protein sequencing by tandem mass spectrometry-. Proc. Natl. Acad. Sci. USA. 83:6233-6237.
36. Mullen, C.A., J.L. Urban, C. van Waes, D.A. Rowley, and H. Schreiber. 1985. Multiple cancers: tumor burden permits the outgrowth of other cancers. J. Exp. Med. 162:1665-1682.
37. Altschul, S.F., W. Gish, W. Miller, E.W. Myers, and D.J. Lipman. 1990. Basic local alignment search tool. J. Mol. Biol. 215:403-410.
38. Lemaire, L., and U.A.O. Heinlein. 1992. High-level expression in male germ cells of murine p68 RNA helicase mRNA. Life Sci. 52:917-926.
39. Brash, D.E., J.A. Rudolph, J.A. Simon, A. Lin, G.J. McKenna, J.P. Baden, A.J. Halperin, and J. Ponten. 1991. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc. Natl. Acad. Sci. USA. 90:4216-4220.
40. Falk, K., O. Rötzschke, S. Stevanovic G. Jung, and H.-G. Rammensee. 1991. Allele-specific motifs revealed by sequencing of self peptides eluted from MHC molecules. Naturc (Lond.). 351:290-296.
41. Schmidt, S.R., and P. Linder. 1992. D-E-A-D protein family of putative RNA helicases. Mol. Microbiol. 6:283-292.
42. Akao, Y., O. Marukawa, H. Monkawa, K. Nakao, M. Kamei, T. Hachiya, and Y. Tsujimoto. 1995. The rck/p54 candidate proto-oncogene product is a 54-kilodalton D-E-A-D box protein differentially expressed in human and mouse tissues. Cancer Res. 55:3444-3449.
43. Fellis, N.A., J. Groden, T. Ye, J. Straugen, D.J. Lennon, S. Ciocci, M. Proytcheva, and J. German. 1995. The Bloom's syndrome gene product is homologous to rec Q helicases. Cell. 83:655-666.
44. Yu, C., J. Oshima, Y. Fu, E.M. Wijsman, F. Hisama, R. Alisch, S. Matthews, J. Nakura, T. Miki, S. Ouais, G.M. Martin, and J. Mulligan. 1996. Positional cloning of the Werner's syndrome gene. Science (Wash. DC.). 272:258-262.
45. Lane., D.P., and W.K. Hoeffler. 1980. SV40 large T shares an antigenic determinant with a cellular protein of molecular weight 68,000. Nature (Lond.). 288:167-170.
46. Ford, M.J., I.A. Anton, and D.P. Lane. 1988. Nuclear protein with sequence homology to translation initiation factor eIF-4A. Nature (Lond.). 332:736-738.
47. Hiding, H., M. Scheffner, T. Restle, and H. Stahl. 1989. RNA helicase activity associated with the human p68 protein. Nature (Lond.). 339:562-564.
48. Iggo, R.D. and D.P. Lane. 1989. Nuclear protein p68 is an RNA-dependent ATPase. EMBO (Eur. Mol. Biol. Organ.) J. 8:1827-1831.
49. Iggo, R.D., D.J. Jamieson, S.A. MacNeill ,J. Southgate, J. McPheat, and D.P. Lane. 1991. p68 RNA helicase: identification of a nucleolar form and cloning of related genes containing a conserved intron in yeast. Mol. Cell. Biol. 11:1326-1333.
50. Buelt, M.K., B.J. Glidden, and D.R. Storm. 1994. Regulation of p68 RNA helicase by calmodulin and protein kinase C. J. Biol. Chem. 269:29367-29370.
51. Oberosler, P., P. Hloch, U. Ramsperger, and H. Stahl. 1993. p53-catalyzed annealing of complementary single-stranded nucleic acids. EMBO (Eur. Mol. Biol. Organ.) J. 12:2389-2396.
52. Lane, D.P. 1992. p53, guardian of the genome. Nature (Lond.). 350:15-16.
53. Nowell, P.C. 1976. The clonal evolution of tumor cell populations. Science (Wash. DC.). 194:23-28.